Bilge Aktaş

681 total citations
20 papers, 505 citations indexed

About

Bilge Aktaş is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Bilge Aktaş has authored 20 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Bilge Aktaş's work include Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (4 papers) and BRCA gene mutations in cancer (4 papers). Bilge Aktaş is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (4 papers) and BRCA gene mutations in cancer (4 papers). Bilge Aktaş collaborates with scholars based in Türkiye, United States and Hungary. Bilge Aktaş's co-authors include Lajos Pusztai, Christos Hatzis, Erin Hofstatter, Tara Sanft, Balázs Győrffy, Ramazan Kurt, Erol Avşar, Cem Kalaycı, Neşe İmeryüz and Yusuf Yılmaz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Bilge Aktaş

18 papers receiving 498 citations

Peers

Bilge Aktaş

ONCOL

EPIDE

PRM

Takaaki Imamura Japan

Xiaoxu Ge China

Christopher J. Darus United States

Wen Wei China

Quentin Bayard France

Olsi Gjyshi United States

Hui-Lan Rao China

Laura Belvederesi Italy

Farrell Adkins United States

Takaaki Imamura Japan

Bilge Aktaş

351 ×1.3

182 ×1.0

181 ×1.2

ONCOL

126 ×1.7

EPIDE

73 ×1.0

PRM

Citations per year, relative to Bilge Aktaş Bilge Aktaş (= 1×) peers Takaaki Imamura

Countries citing papers authored by Bilge Aktaş

Since Specialization

Citations

This map shows the geographic impact of Bilge Aktaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilge Aktaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilge Aktaş more than expected).

Fields of papers citing papers by Bilge Aktaş

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilge Aktaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilge Aktaş. The network helps show where Bilge Aktaş may publish in the future.

Co-authorship network of co-authors of Bilge Aktaş

This figure shows the co-authorship network connecting the top 25 collaborators of Bilge Aktaş. A scholar is included among the top collaborators of Bilge Aktaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilge Aktaş. Bilge Aktaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alan, Özkan, Tuğba Akın Telli, Bilge Aktaş, et al.. (2020). Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?. World Journal of Surgical Oncology. 18(1). 22 indexed citations

Kaya, Serap, Bilge Aktaş, Mehmet Akif Öztürk, et al.. (2019). Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.. PubMed. 22(5). 1191–1198. 1 indexed citations

Gümüş, Mahmut, Serap Kaya, Özkan Alan, et al.. (2019). Neoadjuvant treatment in patients with locally advanced gastric cancer.. Journal of Clinical Oncology. 37(4_suppl). 127–127. 1 indexed citations

Çetin, Bülent, Bilge Aktaş, Öznur Bal, et al.. (2018). Classic Kaposi's sarcoma: A review of 156 cases. Dermatologica Sinica. 36(4). 185–189. 4 indexed citations

Sanft, Tara, Alyssa Berkowitz, Brock E. Schroeder, et al.. (2017). Health economic impact of breast cancer index (BCI) in patients with hormone responsive breast cancer (HRBC) considering extended adjuvant endocrine therapy (EET).. Journal of Clinical Oncology. 35(8_suppl). 25–25. 1 indexed citations

Wali, Vikram B., Casey G. Langdon, Matthew A. Held, et al.. (2016). Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. Cancer Research. 77(2). 566–578. 38 indexed citations

Aktaş, Bilge, et al.. (2015). Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer. European Journal of Cancer Prevention. 25(1). 3–8. 10 indexed citations

Aktaş, Bilge. (2015). CDK inhibitors in hormone receptor positive advanced breast cancer. DergiPark (Istanbul University). 28(4). 35–35.

Sanft, Tara, Bilge Aktaş, Brock E. Schroeder, et al.. (2015). Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer. Breast Cancer Research and Treatment. 154(3). 533–541. 27 indexed citations

10.

Sanft, Tara, Bilge Aktaş, Brock E. Schroeder, et al.. (2015). Prospective study of the decision-making impact of the Breast Cancer Index in the selection of patients with ER+ breast cancer for extended endocrine therapy.. Journal of Clinical Oncology. 33(15_suppl). 538–538. 1 indexed citations

11.

Győrffy, Balázs, Christos Hatzis, Tara Sanft, et al.. (2015). Multigene prognostic tests in breast cancer: past, present, future. Breast Cancer Research. 17(1). 11–11. 181 indexed citations

12.

Ünal, Olçun Ümit, İlhan Öztop, Ozan Yazıcı, et al.. (2014). Treatment and Prognostic Factors in Primary Peritoneal Carcinoma: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO). Oncology Research and Treatment. 37(6). 332–338. 7 indexed citations

13.

Aktaş, Bilge, Hongxia Sun, Hui Yao, et al.. (2014). Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue. Molecular Oncology. 8(3). 717–727. 17 indexed citations

14.

Ünal, Olçun Ümit, İlhan Öztop, Fahriye Tuğba Köş, et al.. (2014). Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO). Asian Pacific Journal of Cancer Prevention. 15(22). 9687–9692. 1 indexed citations

15.

Seber, S., Mehmet Küçüköner, Özlem Sönmez, et al.. (2013). Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention. 14(9). 5185–5188. 8 indexed citations

16.

Demırcı, Umut, Bilge Aktaş, Ahmet Alacacıoğlu, et al.. (2013). Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO). Journal of Cancer Research and Clinical Oncology. 139(5). 829–835. 7 indexed citations

17.

Kepez, Alper, et al.. (2012). Takotsubo cardiomyopathy in a patient with lung adenocarcinoma. SHILAP Revista de lepidopterología. 13(3). 107–107. 7 indexed citations

18.

Aras, Mustafa, et al.. (2012). FDG PET/CT Appearance of Portal Vein Tumor Thrombus in the Gastric Primitive Neuroectodermal Tumor. Clinical Nuclear Medicine. 38(1). 47–49. 8 indexed citations

19.

Yılmaz, Yusuf, Fatih Eren, Oya Yönal, et al.. (2010). Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. European Journal of Clinical Investigation. 40(10). 887–892. 163 indexed citations

20.

Aktaş, Bilge, et al.. (2002). ATTITUDE, BEHAVIOUR AND AWARENESS OF TURKISH WOMEN CONCERNING BREAST CANCER. Marmara medical journal. 15(2). 97–102. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact